
Anti-Aging Compound Polyamines May Also Drive Cancer Growth
Tokyo researchers discovered that polyamines activate different proteins in healthy versus cancerous cells, explaining their paradoxical dual role in longevity and tumor growth.
- Polyamines activate eIF5A1 in healthy cells but eIF5A2 in cancer cells
- The switch mechanism involves disruption of a regulatory molecule miR-6514-5p
- eIF5A2 identified as potential drug target for cancer treatment
